Japan’s Ministry Confirms Efficacy For Booster Inoculation Of Avian Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare released April 6 a trial result for pre-pandemic avian flu vaccine. To confirm efficacy and safety, the trial was conducted last summer and 5,971 medical workers in Japan were given the vaccines produced based on H5N1 flu virus. The ministry found that compared to vaccination using only one flu vaccine, a booster inoculation of a different vaccine was effective in building immunity to a wide range flu viruses. Based on the results, the ministry will decide later this year whether to conduct vaccinations prior to a flu pandemic. (Click here for more - Japanese language
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.